Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer
Catalyst OrthoScience Inc. (Catalyst), an MCPF III medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D. as chief strategy officer of the organization, effective immediately.
“The board and I are excited to have an executive with Dr. Ables’ experience and leadership join our team at Catalyst OrthoScience,” said Catalyst CEO and President Carl O’Connell. “We are committed to building a world class organization focused on our customer’s success and our market impact. Dr. Ables’ leadership will help make that vision a reality, guiding us as we build greater proficiency and organizational competency to accelerate growth and scale our operations.”
“I am grateful and excited to embrace this opportunity with the Catalyst team and to return to my professional roots in shoulder orthopedics,” said Ables. “I look forward to contributing with vigor and vision, steering our efforts toward growth and excellence with strategies that are both responsive to the present and attune to the necessary investments for our future success.”
Ables brings nearly 20 years of medical device experience to Catalyst, including more than a decade in upper extremity orthopedics. She has held leadership roles in sales, marketing, medical education and sales training at Tornier and Wright Medical before departing for ATEC spine.
Read more about the new addition to the Catalyst team here